INTCO MEDICAL(SZ:300677) Sou Hu Cai Jing·2025-10-29 15:34Core Viewpoint - As of October 29, 2025, Yingke Medical (300677) closed at 38.91 yuan, with a slight increase of 0.91% and a trading volume of 15.34 million shares, amounting to a total transaction value of 5.91 billion yuan [1] Financial Performance - For the first three quarters of 2025, Yingke Medical reported a main business revenue of 7.425 billion yuan, a year-on-year increase of 4.6%, and a net profit attributable to shareholders of 924 million yuan, up 34.47% year-on-year [3] - The third quarter of 2025 saw a single-quarter main business revenue of 2.511 billion yuan, a decrease of 2.9% year-on-year, while the single-quarter net profit attributable to shareholders was 214 million yuan, an increase of 113.04% year-on-year [3] - The company’s gross profit margin stands at 23.7%, with a net profit margin of 12.82% [3] Market Position - Yingke Medical has a total market capitalization of 25.478 billion yuan, ranking 8th in the medical device industry [3] - The company’s price-to-earnings ratio (P/E) is 20.67, significantly lower than the industry average of 59.7, ranking 11th in the industry [3] - The company’s return on equity (ROE) is 5.19%, which is higher than the industry average of 2.88%, ranking 46th in the industry [3] Capital Flow Analysis - On October 29, 2025, the net outflow of main funds was 20.3013 million yuan, accounting for 3.43% of the total transaction value, while retail investors saw a net inflow of 57.8882 million yuan, representing 9.79% of the total transaction value [1][2] - Over the past five days, the stock has experienced fluctuations in capital flow, with significant net outflows from main and speculative funds on several days [2]